Anand Kiran Parikh
Chief Operating Officer at Faeth Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 8 months
- Director since
- 2026
8 months of board service in total across 1 board, counting each seat separately. Longest: Faeth Therapeutics Inc., 8 months.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 30, 2026 | Faeth Therapeutics Inc. | Gift | −100,000 | — | — |
| Oct 30, 2026 | Faeth Therapeutics Inc. | Gift | +100,000 | — | — |
| Jun 22, 2026 | Faeth Therapeutics Inc. | Open-market purchase | +2,806 | $19.76 | $55,447 |
| Jun 22, 2026 | Faeth Therapeutics Inc. | Option exercise | +45,252 | $1.16 | $52,492 |
| Jun 22, 2026 | Faeth Therapeutics Inc. | Option exercise | +8,213 | $1.16 | $9,527 |
| Jun 15, 2026 | Faeth Therapeutics Inc. | Derivative conversion | +761,428 | — | — |
Questions about Anand Kiran Parikh
What boards is Anand Kiran Parikh on?
Anand Kiran Parikh sits on the board of Faeth Therapeutics Inc.
What company is Anand Kiran Parikh the CEO of?
Anand Kiran Parikh is President and CEO of Faeth Therapeutics Inc.
How long has Anand Kiran Parikh served on boards?
Our records show at least 8 months of board service across 1 board, the earliest from 2026.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.